Home/Companies/CIK 0000351721
A
ISSUER//CIK 0000351721

ADVANCED NEUROMODULATION SYSTEMS INC

Exchange

Entity type

operating

Fiscal year end

Dec 31

Headquarters

TX

Research Summary

AI-assisted · Grounded in filings

Updated Nov 24, 2025

ADVANCED NEUROMODULATION SYSTEMS INC

Advanced Neuromodulation Systems Inc. operates within the Surgical & Medical Instruments & Apparatus SIC group, designing and delivering neurostimulation devices intended for interventional neurologists, pain specialists, and hospital systems seeking minimally invasive therapies for chronic pain and movement disorders; its product portfolio includes implantable pulse generators and lead technology that support personalized stimulation protocols, capitalizing on the trend toward precision, device-enabled care in the surgical instruments realm. The company’s value proposition hinges on close clinical partnerships, ongoing surgeon education, and a commitment to warranty-backed service for implant maintenance, but it also navigates material risks tied to the stringent regulatory environment, including ongoing FDA oversight, device approval pathways, recall exposure, and the need to sustain reimbursement levels under volatile healthcare policy, all underscored in its most recent Form 10-Q filed in November 1999. CIK 351721 maintains that vigilance, so visit Earnings Feed to view live SEC filings.